Form 8-K - Current report:
SEC Accession No. 0001493152-23-010652
Filing Date
2023-04-03
Accepted
2023-04-03 16:45:34
Documents
20
Period of Report
2023-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49470
2 ex4-1.htm EX-4.1 127706
3 ex4-2.htm EX-4.2 120155
4 ex5-1.htm EX-5.1 22364
5 ex10-1.htm EX-10.1 101637
6 ex10-2.htm EX-10.2 298151
7 ex99-1.htm EX-99.1 16946
8 ex5-1_001.jpg GRAPHIC 4302
9 ex99-1_001.jpg GRAPHIC 5336
  Complete submission text file 0001493152-23-010652.txt   1084466

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE rnxt-20230330.xsd EX-101.SCH 3227
11 XBRL LABEL FILE rnxt-20230330_lab.xml EX-101.LAB 34916
12 XBRL PRESENTATION FILE rnxt-20230330_pre.xml EX-101.PRE 22789
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3872
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 23793414
SIC: 2834 Pharmaceutical Preparations